Pregled bibliografske jedinice broj: 169211
Comparison of the values of basic fibroblast growth factor determined by an immunoassay in the sera of patients with traumatic brain injury and enhanced osteogenesis and the effects of the same sera on the fibroblast growth in vitro
Comparison of the values of basic fibroblast growth factor determined by an immunoassay in the sera of patients with traumatic brain injury and enhanced osteogenesis and the effects of the same sera on the fibroblast growth in vitro // European journal of clinical chemistry and clinical biochemistry, 33 (1995), 10; 693-698 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 169211 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Comparison of the values of basic fibroblast
growth factor determined by an immunoassay in the
sera of patients with traumatic brain injury and
enhanced osteogenesis and the effects of the same
sera on the fibroblast growth in vitro
Autori
Wildburger, Renate ; Žarković, Neven ; Egger, Gerd ; Petek, Walter ; Meinitzer, Andreas ; Borović, Suzana ; Žarković, Kamelija ; Li, Libin ; Stipančić, Igor ; Trbojević Čepe, Milica ; Čvoriscec, Dubravka ; Doko, Marko
Izvornik
European journal of clinical chemistry and clinical biochemistry (0939-4974) 33
(1995), 10;
693-698
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Head-injury ; Affinity-chromatography ; Heparin-sepharose ; Pituitary ; Invitro ; Callus ; Fgf
Sažetak
In patients with severe traumatic brain injury, the early healing of fractures is accompanied by hypertrophic callus formation or heterotopic ossifications, which might even result in ankylosis of the affected joints. Analysis of the sera of patients with traumatic brain injury revealed post- traumatic dynamic changes of basic fibroblast growth factor immunoreactivity, similar to those observed during fracture healing associated with enhanced osteogenesis. The aim of this study was to determine whether such changes in basic fibroblast growth factor concentrations could be related to the phenomenon of enhanced osteogenesis. Basic fibroblast growth factor immunoreactivity was determined (using an IEMA kit) in the sera of patients with traumatic brain injury and bone fractures (n = 8) and in the sera of patients with either traumatic brain injury alone (n = 10) or bone fractures alone (n = 7), and the effects of these sera on L929 fibroblast growth were analysed in vitro. The results did not prove a causative relationship between the changes of basic fibroblast growth factor immunoreactivity and in vitro growth promoting effects of the sera. However, it is apparent that, in addition to changes in the growth-promoting activity and basic fibroblast growth factor concentration of serum, other as yet unknown post-traumatic changes can cause enhanced osteogenesis.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Marko Doko
(autor)
Dubravka Čvoriščec
(autor)
Suzana Borović Šunjić
(autor)
Igor Stipančić
(autor)
Kamelija Žarković
(autor)
Neven Žarković
(autor)
Milica Trbojević-Čepe
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Index Medicus
- PubMed